Oncternal Therapeutics Inc. diskutieren
Oncternal Therapeutics Inc.
WKN: A2PL3P / Symbol: ONCT / Name: Oncternal Therapeutics / Aktie / Small Cap /
0,32 €
4,71 %
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its "buy" rating re-affirmed by analysts at Brookline Capital Management.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $14.00 to $9.00. They now have an "outperform" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Der Beitrag wird untersucht
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) was upgraded by analysts at Brookline Capital Management from a "hold" rating to a "buy" rating. They now have a $2.00 price target on the stock.
Ratings data for ONCT provided by MarketBeat
Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Neueste Beiträge
Jefferies_Financial_ in Daqo New Energy ADR diskutieren